MDMA Statement on Dr. Price's Confirmation as HHS Secretary
Friday, February 10, 2017
MDMA Statement on Dr. Price’s Confirmation as HHS Secretary
WASHINGTON, DC -- Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding Congressman Tom Price’s confirmation as the next Secretary of Health and Human Services (HHS):
“MDMA congratulates Dr. Price on his confirmation as the next Secretary of HHS and we look forward to working with him to ensure that patients and providers gain timely access to the cures and therapies that our members and all medical technology innovators develop.
“Our nation continues to have numerous challenges facing the health care ecosystem, and medical technologies are what drive improvements in patient care, while reducing costs. MDMA remains committed to working with FDA, CMS and all stakeholders to strengthen the environment for innovation, and we know that Dr. Price’s passionate focus on patient access will help us accomplish our common goals of improving outcomes.”